Skip to main content
Surgical Case Reports
Fig. 7 | Surgical Case Reports

Fig. 7

From: Long-term survival of a patient with small cell carcinoma of the stomach with metachronous lung metastases treated by multimodal therapy: a case report

Fig. 7

Summary of postoperative course. After recurrence in the lung at 27 months after surgery, the patient was administered first-line chemotherapy with radiation for 5 months. The clinical effect was CR. However, regrowth was recognized at 39 months. We administered second-line chemotherapy for 10 months and third-line chemotherapy for 4 months. The tumor slightly increased. Therefore, we administered fourth-line chemotherapy for 2 months. However, the patient had severe adverse effects. Moreover, the tumor increased and a swollen lymph node was recognized at 58 months. We changed to fifth-line chemotherapy. However, the tumor increased and effusion developed at 64 months. We administered sixth-line chemotherapy for 7 months. The tumor in the lung had not changed, but brain (69 months) and bone metastases (72 months) were recognized. The serum level of CYFRA was initially slightly elevated; it became upregulated with the development of progressive disease, finally reaching >30 ng/mL with brain and bone metastases. The CEA and CA19-9 levels were within the reference range

Back to article page